Search

Your search keyword '"null Gärtner"' showing total 9 results
Start Over Author "null Gärtner"
9 results on '"null Gärtner"'

1. IV. Referate

Author

null Bützler, null Gärtner, null Hahn, null Hell, S. Herzog, null Kr, uger, null Lutz, and null Wagner

Subjects
Ecology, Animal Science and Zoology, Management, Monitoring, Policy and Law, Ecology, Evolution, Behavior and Systematics, Nature and Landscape Conservation
Published
1999
Full Text
View/download PDF

2. Vererbungswissenschaft und Rassenhygiene

Author

null Hofmann, null Scheurlen, null Heberer, null Lüth, H. Glatzel, null Tiling, Rudolf Abderhalden, null Blumberger, null Ostertag, null Romberg, null Siemens, null Poczka, null Günther, null Portius, null Plachetsky, null Hoenig, null Kresiment, null Gärtner, null Luxemburger, null Gasteiger, H. W. Kranz, null Barth, L. Hüsch, null Wette, null Stutte, and null Haubold

Subjects
Pathology and Forensic Medicine
Published
1938
Full Text
View/download PDF

3. Verletzungen, Gewaltsamer Tod aus physikalischer Ursache

Author

R. Gutzeit, null Karbe, Stefan Kartal, null Salinger, Gebhard Hromada, null Gärtner, null Zillmer, null Matwejeff, null Autoreferat, null Romanese, null Schönberg, Hans Kloiber, null Walcher, H. Merkel, null Colmers, and null Ravasini

Subjects
Medicine (miscellaneous), General Medicine, Law, Pathology and Forensic Medicine
Published
1931
Full Text
View/download PDF

4. Venerische Krankheiten

Author

null Löwenhardt, null Lesser, null Rich, null Kohn, null Dornisr, Karl Herxheimer, null Harttung, null Chotzen, null Jadassohn, null Finger, null Epstein, null Kopp, null Szadek, null Jacobi, null Watraszewski, null Gärtner, null Toeplitz, null Laschkewitsch, and null Block

Subjects
Dermatology, General Medicine
Published
1887
Full Text
View/download PDF

5. Allgemeine Pathologie und pathologische Anatomie

Author

null Thomas, null Spiecker, null Hellner, null Nestmann, E. König, F. Eisler, null Wortmann, null Jendralski, null Schrader, null Noel, F. Scheminzky, null Kyrieleis, null Trendtel, null Esser, null Meixner, null Gärtner, H. Pfister, null Ganter, null Flügel, null Hiller, L. Wachholz, null Nippe, null Kranzfelder, null Schönberg, B. Mueller, G. Strassmann, P. Fraenckel, null Schwarzacher, null Leibbrand, null Deus, null Walcher, Otto Strauβ, null Roth, null Kessel, null Ravasini, null Koritzinsky, null Mayser, E. Vincke, and null Heel

Subjects
Medicine (miscellaneous), General Medicine, Law, Pathology and Forensic Medicine
Published
1936
Full Text
View/download PDF

6. In vitro-Aktivität von Enoxacin: Eine multizentrische Studie

Author

B. Wiedemann, D. Adam, A. Bauernfeind, Christa Blasius, I. Braveny, F. Daschner, H. Grimm, null Gärtner, H. Hahn, Heike Langmaack, Friederike Ley, W. Opferkuch, G. Peters, H. P. Rohr, G. Ruckdeschel, and H. Kraeft

Subjects
Microbiology (medical), biology, Pseudomonas aeruginosa, business.industry, General Medicine, biology.organism_classification, medicine.disease_cause, medicine.disease, Enterobacteriaceae, Cystic fibrosis, Enterococcus faecalis, In vitro, Microbiology, Infectious Diseases, Staphylococcus aureus, medicine, Enoxacin, business, Bacteria, medicine.drug
Abstract

The in vitro activity of enoxacin was tested in 14 German microbiological centers shortly after the introduction of the drug in Germany. 2748 unselected clinical isolates including 15 bacterial species were analysed using microtiter plates. The MIC90-values were as follows: Staphylococcus aureus 4 mg/l, Enterococcus faecalis 16 mg/l, Enterobacteriaceae 0.5 mg/l, Pseudomonas aeruginosa 8 mg/l. There is good correlation between these results and those of former investigations. It is known that quinolones are only moderately active against enterococci. 8.5% of S. aureus, and 1.4% of Enterobacteriaceae were found to be resistant (MIC greater than 4 mg/l). As to P. aeruginosa, the study revealed that despite a generally low rate of resistance in specific clinical settings, specific problems can arise: in one institution, the MIC90 of P. aeruginosa was 32 mg/l, with a resistance rate of 56.1% (n = 57). In the other centers the MIC90 was 2 mg/l and the resistance rate 5.0% (n = 302). In the first center, many of the isolates were from paraplegic patients or patients with cystic fibrosis pretreated with quinolones. This study will be repeated in two years' time in order to determine an eventual change in resistance.

Published
1989
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results